Fifth Third Bancorp ( FITB ) has recently inked a deal to buy back about $125 million of its outstanding common stock. The share repurchase deal reached with Credit Suisse International,
Merck ( MRK ) recently announced that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for its insomnia candidate, suvorexant.